MAY 10, 2021 12:22 PM PDT

Advancements in nanotech pave the way for improved chemotherapy

New research from Massachusetts General Hospital (MGH) reports on a development in improving the effectiveness of chemotherapy. The technique works by binding albumin to chemotherapy drugs, which causes cancer cells to attach to them. 

This strategy has already been approved for a nanoparticle albumin-bound paclitaxel (nab-PTX)  that treats late-stage lung and pancreatic cancers. But, explains senior author Miles Miller, PhD, "Not all patients respond to nab-PTX, though, and the effectiveness of its delivery to tumors has been mixed, owing to an incomplete understanding of how albumin impacts drug delivery and actions.” Miller is a principal investigator in the MGH Center for Systems Biology and an assistant professor of Radiology at Harvard Medical School. 

In order to address this lack of understanding, the researchers employed 3D microscopy and tissue clearing technology in mice models to analyze the uptake of nab-PTX by cancer cells. They observed how the consumption of nab-PTX is controlled by signaling pathways that are related to the uptake of certain nutrients - particularly albumin.  

"This discovery suggested that if we could manipulate these pathways, we might be able to trick cancer cells into a nutrient-starved state, thereby enhancing their consumption of nab-PTX," explains first author Ran Li, Ph.D., who is an instructor in the MGH Department of Radiology and the Center for Systems Biology. The team’s subsequent testing proved this hypothesis. 

The findings are published in the journal Nature Nanotechnology. "These results offer new possibilities to improve delivery of albumin-bound drugs in patients with diverse types of cancer," concludes Miller.

Sources: Nature Nanotechnology, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
SEP 15, 2021
Cell & Molecular Biology
The Molecular 'Anchors' That Hold Cells in Place
SEP 15, 2021
The Molecular 'Anchors' That Hold Cells in Place
Cells in the body are held in place with a kind of molecular anchor, called focal adhesions, where cells are linked to c ...
SEP 22, 2021
Cancer
Whole Genome Sequencing for Cancer Diagnostics
SEP 22, 2021
Whole Genome Sequencing for Cancer Diagnostics
The human genome consists of genetic material known as DNA.  We all have unique DNA sequences made up of four bases ...
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
NOV 08, 2021
Cancer
Genetic Explanation for Low Cancer Incidence in Elephants
NOV 08, 2021
Genetic Explanation for Low Cancer Incidence in Elephants
Elephants possess two qualities that might make one expect they are at high risk of developing cancer; they are large an ...
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
Loading Comments...